Summary : Western Resources Corp. is pleased to announce that it has signed a subscription agreement (the “Subscription Agreement”) today with Vantage…
Development
-
-
Pharma Science & Research
Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
by adminby adminSummary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease…
-
CompaniesPfizer
Lawsuit over Pfizer’s disclosures before Chantix recall is dismissed
by adminby adminSummary : A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to…
-
Covid DrugsGlobal Market
Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
by adminby adminSummary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
-
Global MarketPharma Science & Research
Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs
by adminby adminSummary : Spain’s Rovi (ROVI.MC) has agreed a 10-year extension to its deal with Moderna (MRNA.O) to manufacture future drugs developed with…
-
IndiaMankind Pharma
Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Laboratories
by adminby adminSummary : Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy’s Laboratories to acquire two brands — Combihale and Daffy. While Combihale…
-
RegulatoryU.S FDA
Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tablets
by adminby adminSummary: Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug…
-
Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health…
-
Pharma Science & Research
Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy
by adminby adminSummary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in…
-
Covid DrugsIndia
Emcure Pharma arm developing Covid vaccine targeting Omicron variant
by adminby adminSummary : India’s Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two,…